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The analgesic efficacy of opioids is well known to vary widely among individuals, and vari-
ous factors related to individual differences in opioid sensitivity have been identified. How-
ever, a prediction model to calculate appropriate opioid analgesic requirements has not yet
been established. The present study sought to construct prediction formulas for individual
opioid analgesic requirements based on genetic polymorphisms and clinical data from pa-
tients who underwent cosmetic orthognathic surgery and validate the utility of the prediction
formulas in patients who underwent major open abdominal surgery.
Methods
To construct the prediction formulas, we performed multiple linear regression analyses
using data from subjects who underwent cosmetic orthognathic surgery. The dependent
variable was 24-h postoperative or perioperative fentanyl use, and the independent vari-
ables were age, gender, height, weight, pain perception latencies (PPL), and genotype data
of five single-nucleotide polymorphisms (SNPs). To examine the utility of the prediction for-
mulas, we performed simple linear regression analyses using subjects who underwent
major open abdominal surgery. Actual 24-h postoperative or perioperative analgesic use
and the predicted values that were calculated using the multiple regression equations were
incorporated as dependent and independent variables, respectively.
Results
Multiple linear regression analyses showed that the four SNPs, PPL, and weight were re-
tained as independent predictors of 24-h postoperative fentanyl use (R2 = 0.145, P = 5.66 ×
10-10) and the two SNPs and weight were retained as independent predictors of periopera-
tive fentanyl use (R2 = 0.185, P = 1.99 × 10-15). Simple linear regression analyses showed
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that the predicted values were retained as an independent predictor of actual 24-h postoper-
ative analgesic use (R2 = 0.033, P = 0.030) and perioperative analgesic use (R2 = 0.100,
P = 1.09 × 10-4), respectively.
Conclusions
We constructed prediction formulas, and the possible utility of these prediction formulas
was found in another type of surgery.
Introduction
Opioid analgesics are widely used for the treatment of moderate to severe pain during the peri-
operative period. However, the analgesic efficacy of opioids is well known to vary widely
among individuals [1]. For example, the minimal effective analgesic concentration of fentanyl
that is required for satisfactory analgesia varies from 0.2 to 2.0 ng/ml among patients [2]. Thus,
effective pain treatment is often hampered by significant differences in opioid sensitivity
(S1 Fig.). Inadequate pain relief because of insufficient doses of opioids and adverse side-effects
caused by unnecessarily high doses of opioids (e.g., nausea, vomiting, and constipation) are
often observed in clinical settings [3]. The proper administration of opioids that meets the
needs of individual patients is crucial.
Individual differences can be attributed to both environmental and genetic factors, although
the relative influence of each of these factors can be variable [4]. For example, this variation in
postoperative pain and analgesic consumption is reportedly affected by environmental factors
including hepatic or renal function, type of surgery, and anesthesia method, demographic fac-
tors including gender, age, and ethnic origin, and preexisting psychophysical factors including
anxiety and preoperative pain [4–6]. Additionally, a recent study that included identical and
fraternal twins revealed that an estimated 60% of the variance in cold-pressor pain and 26% of
the variance in heat pain were genetically mediated. Thus, some individual differences are like-
ly to be attributable to genetic factors [7]. To date, various candidate genetic polymorphisms
related to individual opioid sensitivity have been revealed and in particular several genetic
polymorphisms within or close to regions of the OPRM1 gene that encodes opioid receptor,
mu 1, CACNA1E gene that encodes calcium channel, voltage-dependent, R type, alpha 1E sub-
unit, ADRB2 gene that encodes adrenoceptor beta 2, surface, GIRK2 (KCNJ6) gene that en-
codes potassium inwardly-rectifying channel, subfamily J, member 6, and CREB1 gene that
encodes cyclic adenosine 3’,5’-monophosphate responsive element binding protein 1, have
been reported to be strongly associated with opioid requirements in patients who underwent
cosmetic orthognathic surgery with postoperative pain [8–10].
Although various factors related to individual differences in opioid sensitivity have been
identified, a prediction model that calculates appropriate opioid analgesic requirements has
not yet been developed. Therefore, the present study sought to construct prediction formulas
for individual opioid analgesic requirements based on five genetic polymorphisms described
above and clinical data using patients who underwent cosmetic orthognathic surgery. We in-
vestigated patients who underwent mandibular sagittal split ramus osteotomy, which is highly
standardized at our institute regarding surgical procedures, duration of surgery, and the skill of
the surgeons. Because these patients are usually young and healthy and expected to have simi-
lar pain after surgery, they may be ideal for evaluating the analgesic effects of opioids [1, 8]. We
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The study protocol was approved by the Institutional Review Boards at Tokyo Dental College
(Tokyo, Japan), the Institute of Medical Science, The University of Tokyo (Tokyo, Japan),
Toho University Sakura Medical Center (Sakura, Japan), and the Tokyo Institute of Psychiatry
(currently Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan). All of the subjects
and the parents when the subjects were minors provided informed, written consent for the
genetics studies.
Subjects
Enrolled in the initial study to construct the prediction formulas for individual opioid analgesic
requirements were 354 healthy patients (American Society of Anesthesiologists Physical Status
I, age 15–52 years, 126 males and 228 females) who were scheduled to undergo cosmetic
orthognathic surgery (mandibular sagittal split ramus osteotomy) for mandibular prognathism
under general anesthesia at Tokyo Dental College Suidoubashi Hospital. Patients with chronic
pain, those taking pain medication, and those who experienced Raynaud’s phenomenon were
excluded. Peripheral blood samples were collected from these subjects for the gene analysis.
The detailed demographic and clinical data of the subjects are provided in Table 1 and S1
Table.
The subjects who were included in the second analysis to examine the utility of the predic-
tion formulas that were constructed based on multiple regression analysis were different
145 patients (American Society of Anesthesiologists Physical Status I or II, age 28–80 years,
83 males and 62 females) who underwent major open abdominal surgery, mostly gastrectomy
for gastric cancer and colectomy for colorectal cancer under combined general and epidural
anesthesia at the Institute of Medical Science (The University of Tokyo) or Toho University
Sakura Medical Center. Peripheral blood or oral mucosa samples were collected from these
subjects for the gene analysis. The detailed demographic and clinical data of the subjects are
provided in Table 2 and S2 Table.
Table 1. Demographic and clinical data of the subjects who underwent cosmetic orthognathic
surgery.
Age (years) 25.9 ± 7.6 (15–52)
Male/Female 126/228
Height (cm) 164.6 ± 8.8 (143–190)
Body weight (kg) 57.7 ± 10.9 (38–128)
PPL (s) 14 [9, 23] (2–150)
OPRM1 (rs9384179) AA/AG, GG 283/71
CACNA1E (rs3845446) AA/AG, GG 167/187
ADRB2 (rs11959113) AA, AG/GG 153/201
GIRK2 (rs2835859) TT/TC, CC 305/49
CREB1 (rs2952768) CC/TC, TT 35/319
The data are expressed as numbers, mean ± SD (range), or median [interquartile range].
PPL, pain perception latency.
doi:10.1371/journal.pone.0116885.t001
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General anesthesia and postoperative pain management
For the subjects who underwent cosmetic orthognathic surgery, the surgical protocol and sub-
sequent postoperative pain management were fundamentally the same as in previous studies
[8, 9]. The cold pressor-induced pain test was performed before the induction of anesthesia as
previously described [11, 12]. Briefly, crushed ice cubes and cold water were blended 15 min
before testing in a 1 L isolated tank, and the mixture was stirred immediately before each test to
ensure a uniform distribution of temperature (0°C) within the tank. The dominant hand was
immersed up to the wrist. The subjects were instructed to keep their hand calm in the ice-cold
water and withdraw it as soon as they perceived any pain. The same investigator conducted the
test for all of the patients. The baseline latency to pain perception, defined as the time of im-
mersion of the hand in the ice water (pain perception latency [PPL]), was recorded. A cut-off
point of 150 s was set to avoid tissue damage. After the induction of anesthesia, peripheral
blood samples were collected from these subjects for the gene analysis. After emergence from
anesthesia and tracheal extubation, 1.25 mg droperidol was administered intravenously to pre-
vent nausea/vomiting, and intravenous patient-controlled analgesia (PCA) with fentanyl
(1 mg fentanyl and 5 mg droperidol diluted in normal saline in a total volume of 50 ml) com-
menced using a CADD-Legacy PCA pump (Smiths Medical Japan, Tokyo, Japan). The PCA
settings included a bolus dose of 20 μg fentanyl on demand and a lockout time of 10 min. Con-
tinuous background infusion was not used. Droperidol was coadministered with fentanyl to
prevent nausea/vomiting because our preliminary study found a high incidence (up to 30%) of
nausea/vomiting with PCA fentanyl in young females. Patient-controlled analgesia was contin-
ued for 24 h postoperatively. Intraoperative fentanyl use and postoperative PCA fentanyl use
during the first 24-h postoperative period were recorded. The doses of fentanyl administered
intraoperatively and postoperatively were normalized to body weight.
For the subjects who underwent major open abdominal surgery, the surgical protocol and
subsequent postoperative pain management were fundamentally the same as in previous stud-
ies [13, 14]. Postoperative pain was managed primarily with continuous epidural analgesia
with fentanyl or morphine. Fentanyl or morphine was diluted with 0.25% bupivacaine in a
total volume of 100 ml and infused at a constant rate of 2 ml/h through a catheter placed in the
lower thoracic or upper lumbar epidural space. Whenever the patient complained of significant
postoperative pain despite continuous epidural analgesic, appropriate doses of opioids, includ-
ing morphine, buprenorphine, pentazocine, and pethidine, and/or nonsteroidal antiinflamma-
tory drugs (NSAIDs), including diclofenac and flurbiprofen, were administered as rescue
analgesics at the discretion of the surgeons based on the patient’s request. The doses of rescue
Table 2. Demographic and clinical data of the subjects who underwent major open abdominal
surgery.
Age (years) 63.8 ± 9.9 (28–80)
Male/Female 83/62
Height (cm) 158.3 ± 8.5 (133–175)
Body weight (kg) 56.3 ± 10.5 (30–80)
OPRM1 (rs9384179) AA/AG, GG 117/28
CACNA1E (rs3845446) AA/AG, GG 68/77
ADRB2 (rs11959113) AA, AG/GG 63/82
GIRK2 (rs2835859) TT/TC, CC 132/13
CREB1 (rs2952768) CC/TC, TT 17/128
The data are expressed as numbers and mean ± SD (range).
doi:10.1371/journal.pone.0116885.t002
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analgesics (opioids and/or NSAIDs) administered during the first 24-h postoperative period
and dose of analgesics administered during the intraoperative period were recorded. To allow
intersubject comparisons of the analgesic doses required during the intraoperative period and
first 24 h postoperative period, the doses of opioids and NSAIDs administered as rescue analge-
sics during these periods were converted to the equivalent dose of systemic fentanyl according
to previous reports [13–24]. The total dose of analgesics administered was calculated as the
sum of the systemic fentanyl-equivalent doses of all of the opioids and NSAIDs administered
to patients as analgesics during the intraoperative period and first 24-h postoperative period.
Peripheral blood or oral mucosa samples were collected from these subjects after surgery for
the gene analysis.
Genotyping
Genomic DNA was extracted from the oral mucosa or whole-blood samples using the Wizard
Genomic DNA Purification Kit (Promega, Tokyo, Japan) or the QIAamp DNAMini Kit
(Qiagen, Tokyo, Japan) according to the manufacturer’s instructions [25].
For genotyping the five selected single-nucleotide polymorphisms (SNPs; rs9384179 in the
human OPRM1 gene, rs3845446 in the human CACNA1E gene, rs11959113 in the human
ADRB2 gene, rs2835859 in the human GIRK2 [KCNJ6] gene, and rs2952768 around the
human CREB1 gene), direct sequencing, the TaqMan allelic discrimination assay, and Infinium
assay II were used. Genotype data from whole-genome genotyping, which was performed
using Infinium assay II and an iScan system (Illumina, San Diego, CA, USA), were used for the
rs3845446, rs11959113, rs2835859, and rs2952768 SNPs. Direct sequencing was conducted to
genotype the rs9384179 SNP as described in a previous report [8]. The TaqMan allelic discrim-
ination assay was conducted to genotype the rs3845446, rs2835859, and rs2952768 SNPs as de-
scribed in previous reports [9, 10] and the rs11959113 SNP. To perform the TaqMan assay
with a LightCycler 480 (Roche Diagnostics, Basel, Switzerland), we used TaqMan SNP Geno-
typing Assays (Life Technologies, Carlsbad, CA, USA) that contained sequence-specific for-
ward and reverse primers to amplify the polymorphic sequence and two probes labeled with
VIC and FAM dye to detect both alleles of the rs3845446, rs11959113, rs2835859, and
rs2952768 SNPs (Assay ID: C___7539287_30, C__27108051_10, C__16076710_10, and
C__11510543_20, respectively). Real-time polymerase chain reaction was performed in a final
volume of 10 μl that contained 2× LightCycler 480 Probes Master (Roche Diagnostics), 40×
TaqMan SNP Genotyping Assays, 5–50 ng genomic DNA as the template, and H2O (Roche Di-
agnostics). The thermal conditions were the following: 95°C for 10 min, followed by 45 cycles
of 95°C for 10 s and 60°C for 60 s, with final cooling at 50°C for 30 s. Afterward, endpoint fluo-
rescence was measured for each sample well, and each genotype was determined based on the
presence or absence of each type of fluorescence. The details of Infinium assay II for whole-
genome genotyping were provided in a previous report [9].
Statistical analysis
Three hundred fifty-four subjects who underwent painful cosmetic surgery were used for the
initial analysis to construct prediction formulas for individual opioid sensitivity. As an index of
opioid sensitivity, postoperative PCA fentanyl use during the first 24-h postoperative period
was used because analgesic requirements likely reflect the efficacy of fentanyl in each individual
patient. Prior to the analyses, the quantitative values of PPL (in seconds) and postoperative fen-
tanyl requirements (μg/kg) were natural-log-transformed for approximation to the normal dis-
tribution according to the following formulas: Value for analyses = Ln (1 + endpoint PPL value
[s]) and = Ln (1 + postoperative fentanyl requirement [μg/kg]), respectively. To predict 24-h
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postoperative fentanyl requirements from the clinical or genomic parameters that may affect
the analgesic efficacy of fentanyl (i.e., age, gender, height, weight, PPL, and genotype of the five
SNPs), multiple linear regression analysis using the stepwise method of bidirectional selection
was performed. The cut off P value for inclusion was set at 0.05. Moreover, to confirm the utili-
ty of including the five SNPs in the predictive models of 24-h postoperative and perioperative
fentanyl use, we examined whether adding the five SNPs to other patient characteristics in the
models improves its predictive ability using forced entry method. The dependent variable was
24-h postoperative fentanyl use, and the independent variables were age, gender, height,
weight, pain perception latencies, and genotype data of five single-nucleotide polymorphisms
(SNPs). For the analysis, the gender and genotype data for each SNP were used as dummy vari-
ables based on the previous analyses (S3 and S4 Tables) by replacing females and the genotypes
associated with greater fentanyl use with 1, and males and the genotypes associated with lesser
fentanyl use with 0. Therefore, we replaced homozygous carriers of the A allele of the
rs9384179 SNP with 1 and non-carriers with 0, homozygous carriers of the A allele of the
rs3845446 SNP with 1 and non-carriers with 0, carriers of the A allele of the rs11959113 SNP
with 1 and homozygous carriers of the G allele with 0, homozygous carriers of the T allele of
the rs2835859 SNP with 1 and non-carriers with 0, and homozygous carriers of the C allele of
the rs2952768 SNP with 1 and non-carriers with 0, respectively. Similar analysis using subjects
who underwent cosmetic orthognathic surgery was also conducted for analgesic requirements
during the perioperative period instead of during the postoperative period because the analge-
sic effect of the intermediate-acting analgesics, administered pre- and intraoperatively, could
outlast the duration of surgery and thus affect postoperative analgesic use, especially in patients
who received large doses of analgesics intraoperatively. Perioperative fentanyl use was calculat-
ed as the sum of the intraoperative and postoperative doses of fentanyl or fentanyl-equivalent
doses of analgesics.
Second analyses were conducted using the different 145 subjects who underwent major ab-
dominal surgery. The total dose of rescue analgesics administered during the first 24-h postop-
erative period was used as an index of opioid sensitivity. Prior to the analyses, the quantitative
values of postoperative analgesic requirements (μg/kg) were natural-log-transformed for ap-
proximation to the normal distribution according to the following formula: Value for analyses
= Ln (1 + postoperative analgesic requirement [μg/kg]). To explore the regression of the actual
value of 24-h postoperative analgesic requirements after major abdominal surgery to the pre-
dicted value that was calculated using the multiple regression equation constructed in the ini-
tial analysis, simple linear regression analysis was performed. Actual 24-h postoperative
analgesic use (μg/kg; log-transformed) and the predicted value that was calculated were incor-
porated as dependent and independent variables, respectively. Similar analysis using subjects
who underwent major abdominal surgery was also conducted for analgesic requirements dur-
ing the perioperative period instead of during the postoperative period. Perioperative fentanyl
use was calculated as the sum of the intraoperative and postoperative doses of fentanyl or fenta-
nyl-equivalent doses of analgesics.
For all of the statistical analyses described above, IBM SPSS v.20.0 for Windows software
(IBM Japan, Tokyo, Japan) was used.
Results
The R2 value was improved from 0.062 to 0.169 and from 0.127 to 0.208 by adding the five
SNPs to other patient characteristics in the predictive models of 24-h postoperative and periop-
erative fentanyl use, respectively. Initial multiple linear regression analysis of the postoperative
period using the stepwise method showed that the genotype of the four SNPs i.e. rs2952768
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(P = 1.3 × 10-6), rs2835859 (P = 0.003), rs9384179 (P = 0.042), and rs11959113 (P = 0.018),
PPL (P = 0.016), and weight (P = 0.044) were retained as independent predictors of 24-h post-
operative fentanyl use for cosmetic orthognathic surgery (R2 = 0.145, P = 5.66 × 10-10; Fig. 1).
The detailed multiple regression equation is shown in Fig. 2. Similar multiple linear regression
analysis of the perioperative period considering the analgesic effect of intermediate-acting
Fig 1. Regression analysis of 24-h postoperative fentanyl use after cosmetic orthognathic surgery.
The figure shows a scatterplot for the actual value of 24-h postoperative fentanyl use (μg/kg; log-transformed)
in patients who underwent cosmetic orthognathic surgery and the predicted value that was calculated. Each
point represents an individual patient. The solid line in the scatterplot represents the regression line, and the
mathematical formula represents the regression equation.
doi:10.1371/journal.pone.0116885.g001
Fig 2. Construction of prediction formula.Multiple linear regression analysis during the postoperative
period using the stepwise method was performed to construct a prediction formula for individual opioid
sensitivity. “y” represents the predicted value of 24-h postoperative fentanyl requirements (μg/kg; log-
transformed) that was calculated using the multiple regression equation.
doi:10.1371/journal.pone.0116885.g002
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analgesics administered pre- and intraoperatively showed that the genotype of the two SNPs,
rs2952768 (P = 9.1 × 10-5) and rs3845446 (P = 0.001), and weight (P = 2.8 × 10-12) were re-
tained as independent predictors of perioperative fentanyl use for cosmetic orthognathic
surgery (R2 = 0.185, P = 1.99 × 10-15; Fig. 3). The multiple-regression equation was the follow-
ing: predicted value of perioperative fentanyl requirements (μg/kg; log-transformed) = 2.749 +
0.221 × [CREB1] + 0.109 × [CACNA1E] + (-0.011) × [weight (kg)].
Second simple linear regression analysis of the postoperative period using subjects who un-
derwent major abdominal surgery showed that the predicted value that was calculated was re-
tained as an independent predictor of actual 24-h postoperative analgesic use for major
abdominal surgery (R2 = 0.033, P = 0.030; Fig. 4). Similar simple linear regression analysis of
the perioperative period showed that the predicted value that was calculated was retained as
an independent predictor of actual perioperative analgesic use for major abdominal surgery
(R2 = 0.100, P = 1.09 × 10-4; Fig. 5).
Discussion
A prediction formula for individual opioid analgesic requirements during the first 24-h postop-
erative period (Fig. 2) was constructed using multiple linear regression analysis in healthy sub-
jects who underwent painful cosmetic orthognathic surgery. By conducting similar analysis, we
also constructed a prediction formula for the perioperative period, although the variables that
were retained as independent predictors after the analysis of the perioperative period were not
the same as those of the postoperative period (Fig. 3). The R2 index in the prediction formula
for perioperative analgesic requirements was higher than the R2 index for the first 24-h postop-
erative analgesic requirements. Furthermore, by conducting simple linear regression analyses
in subjects who underwent major open abdominal surgery, we demonstrated the possibility
that the prediction formulas may be useful in another type of surgery (Figs. 4 and 5), although
the predictability of the formula remains to be verified in future studies. Using the prediction
formulas and the patients’ genetic polymorphisms and clinical data, better analgesia could be
provided to individual patients. Based on the predicted values, less fentanyl could be
Fig 3. Regression analysis of perioperative fentanyl use after cosmetic orthognathic surgery. The
figure shows a scatterplot for the actual value of perioperative fentanyl use (μg/kg; log-transformed) in
patients who underwent cosmetic orthognathic surgery and the predicted value that was calculated. Each
point represents an individual patient. The solid line in the scatterplot represents the regression line, and the
mathematical formula represents the regression equation.
doi:10.1371/journal.pone.0116885.g003
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administered to patients with higher opioid sensitivity, and more fentanyl could be adminis-
tered to patients with lower opioid sensitivity. For example, setting the appropriate dose of an-
algesics for individual patients by setting an upper level has great potential for safe,
personalized pain control while minimizing potential side effects.
Empirical approaches to the effective treatment of pain are currently limited because the ini-
tial drug selection and subsequent dosage titrations, drug additions, and switches in therapy
are driven by only a few patient-specific clinical features [26]. Thus, pharmacogenetic studies
are being developed to advance personalized medicine. Pharmacogenetics is defined as the use
of pharmacogenomic or pharmacogenetic tests in conjunction with drug therapy and has the
potential to change the way in which healthcare is provided by stratifying patients into likely
Fig 4. Regression analysis of 24-h postoperative analgesic use after major abdominal surgery. The
figure shows a scatterplot for the actual value of 24-h postoperative analgesic use (μg/kg; log-transformed) in
patients who underwent major abdominal surgery and the predicted value that was calculated. Each point
represents an individual patient. The solid line in the scatterplot represents the regression line, and the
mathematical formula represents the regression equation.
doi:10.1371/journal.pone.0116885.g004
Fig 5. Regression analysis of perioperative analgesic use after major abdominal surgery. The figure
shows a scatterplot for the actual value of perioperative analgesic use (μg/kg; log-transformed) in patients
who underwent major abdominal surgery and the predicted value that was calculated. Each point represents
an individual patient. The solid line in the scatterplot represents the regression line, and the mathematical
formula represents the regression equation.
doi:10.1371/journal.pone.0116885.g005
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responders, likely non-responders, and likely to experience adverse drug reactions [27]. The
use of pharmacogenomic principles represents an opportunity to enhance public health and
patient care. Therefore, prediction formulas can be constructed for individual analgesic re-
quirements based on genetic polymorphisms.
Recently, methods of predicting drug requirements using genetic tests may be adopted for
drugs for which dose adjustments are difficult because of large individual differences in sensi-
tivity. For example, a dosing algorithm has been constructed for warfarin, consisting of the pa-
tient’s age, body surface area, state of amiodarone co-administration, and genotype of three
SNPs (R2 = 0.434) [28]. A prospective study reported that an algorithm guided by pharmacoge-
netic and clinical factors improved the accuracy and efficiency of warfarin dose initiation, al-
though a reduction of out-of-range prothrombin time international normalized ratios (INRs)
was not achieved [29]. Thus, prediction formulas have also been constructed and verified for
medications other than opioid analgesics. Although the precision of our prediction formula for
individual opioid analgesic requirements appears to be relatively low in terms of the R2 index
compared with the warfarin dosing algorithm, such algorithms are expected to be improved in
future studies and contribute to personalized medicine.
Gene and opioid-effect relationships are difficult to determine from data that are sampled
from patients with cancer pain because the mechanism, severity, and nature of cancer pain can
differ substantially between patients [30]. Thus, patients with acute postoperative pain after stan-
dardized surgical procedures in the present study may be optimal subjects for investigating such
relationships [1]. The precision of our prediction formulas for individual opioid analgesic re-
quirements was relatively low in terms of the R2 index for major open abdominal surgery com-
pared with cosmetic orthognathic surgery, and several factors may have contributed to this
imprecision. The first consideration is differences in the surgical procedures and the degree of in-
vasiveness. The present study included patients with various diseases and pathologies that re-
quired major abdominal surgery. Another consideration is the analgesics employed and their
routes of administration. Various analgesics and routes of administration are used in major ab-
dominal surgery, and analgesic action, absorption, metabolism, and excretion can vary consider-
ably among analgesics and routes of administration. For example, buprenorphine is long-acting
and antagonizes other opioids, which may prevent the effects of continuous epidural opioids and
other rescue opioids. A third consideration is the pathways of pain. Major abdominal surgery in-
volves visceral pain, and some pain pathways may not be exactly the same as those associated
with cosmetic orthognathic surgery. Therefore, to apply our formulas to other types of surgery,
further investigation is necessary. Future studies should verify the utility of the prediction formu-
las in surgeries that have fewer variations with regard to patients and surgical procedures.
Additionally, studies that investigate the genes that encode opioid metabolizing enzymes
and transporters are also worth performing. Because most opioid drugs are metabolized by cy-
tochrome P450 enzymes (CYPs), including CYP2D6, glucuronidated by UDP-glucuronosyl-
transferases (UGTs), and transported between the blood and brain by ATP-binding cassette,
sub-family B (MDR/TAD), member 1 (ABCB1), the genes that encode these metabolic en-
zymes and transporters are worth examining with regard to differences in analgesic require-
ments [2, 31, 32]. The onset of negative effects (e.g., nausea, vomiting, and constipation) may
also be a useful and interesting outcome because such effects can cause some patients to stop
requesting analgesics despite not actually achieving full analgesia. However, we did not con-
struct prediction formulas for negative effects because the number of patients with adverse
side-effects was small in the present study. Additionally, other variables, such as cigarette
smoking status and pre-existing opioid tolerance, can influence opioid analgesic requirements.
We found that some SNPs were associated with self-reported pain level (data not shown), and
pain level in addition to analgesic requirements may be predicted by gene analyses.
Prediction Formulas for Individual Opioid Analgesic Requirements
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Moreover, gene-gene interactions and gene-environment interactions can also affect opioid
sensitivity, although the present study assumed that each factor was independent. Thus, other
prediction formulas should be constructed by taking these factors into account. Such consider-
ations should aid in the development of more effective personalized pain treatment for patients
who suffer from cancer pain or postoperative pain after various surgeries by predicting opioid
sensitivity based on simple genetic tests.
In conclusion, by conducting multiple linear regression analyses of healthy subjects who un-
derwent painful cosmetic orthognathic surgery, we constructed prediction formulas for indi-
vidual opioid analgesic requirements during the first 24-h postoperative period and
perioperative period. Furthermore, by conducting simple linear regression analyses in subjects
who underwent major open abdominal surgery, we found that these prediction formulas may
be useful for other types of surgery. Although further validation is needed, our data provide
valuable information for the individualization of appropriate fentanyl doses to achieve ade-
quate pain control and open new avenues for personalized pain treatment.
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